Our top pick for
Corteva Inc is an agricultural inputs business based in the US. Corteva shares (CTVA) are listed on the NYSE and all prices are listed in US Dollars. Corteva employs 21,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$42.75|
|52-week range||$30.78 - $49.68|
|50-day moving average||$42.89|
|200-day moving average||$44.48|
|Wall St. target price||$51.89|
|Dividend yield||$0.53 (1.24%)|
|Earnings per share (TTM)||$1.63|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-18)||-1.22%|
|1 month (2021-09-24)||1.04%|
|3 months (2021-07-23)||1.47%|
|6 months (2021-04-23)||-12.09%|
|1 year (2020-10-23)||28.88%|
|2 years (2019-10-25)||59.93%|
|3 years (2018-10-21)||N/A|
|5 years (2016-10-21)||N/A|
Valuing Corteva stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Corteva's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Corteva's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Corteva shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Corteva's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.035. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Corteva's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Corteva's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a Corteva's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$14.9 billion|
|Operating margin TTM||13.14%|
|Gross profit TTM||$5.7 billion|
|Return on assets TTM||2.92%|
|Return on equity TTM||5.32%|
|Market capitalisation||$31.4 billion|
TTM: trailing 12 months
There are currently 11.0 million Corteva shares held short by investors – that's known as Corteva's "short interest". This figure is 12.2% down from 12.6 million last month.
There are a few different ways that this level of interest in shorting Corteva shares can be evaluated.
Corteva's "short interest ratio" (SIR) is the quantity of Corteva shares currently shorted divided by the average quantity of Corteva shares traded daily (recently around 2.8 million). Corteva's SIR currently stands at 3.97. In other words for every 100,000 Corteva shares traded daily on the market, roughly 3970 shares are currently held short.
However Corteva's short interest can also be evaluated against the total number of Corteva shares, or, against the total number of tradable Corteva shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Corteva's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Corteva shares in existence, roughly 20 shares are currently held short) or 0.017% of the tradable shares (for every 100,000 tradable Corteva shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Corteva.
Find out more about how you can short Corteva stock.
Dividend payout ratio: 28.8% of net profits
Recently Corteva has paid out, on average, around 28.8% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.31% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Corteva shareholders could enjoy a 1.31% return on their shares, in the form of dividend payments. In Corteva's case, that would currently equate to about $0.53 per share.
While Corteva's payout ratio might seem fairly standard, it's worth remembering that Corteva may be investing much of the rest of its net profits in future growth.
Corteva's most recent dividend payout was on 14 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
Over the last 12 months, Corteva's shares have ranged in value from as little as $30.7756 up to $49.6837. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Corteva's is 0.8252. This would suggest that Corteva's shares are less volatile than average (for this exchange).
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.